Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?

George Kunos*, Tony Jourdan, Joseph Tam

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageAmerican English
Article numbere155330
JournalJournal of Clinical Investigation
Issue number1
StatePublished - 4 Jan 2022


  • Endocannabinoids
  • Humans
  • Insulin Resistance
  • Liver
  • Non-alcoholic Fatty Liver Disease/genetics

Cite this